206 related articles for article (PubMed ID: 17970003)
1. Histology of specimens taken by prostatectomy and needle biopsy.
Ngugi PM; Byakika B
East Afr Med J; 2007 Aug; 84(8):363-6. PubMed ID: 17970003
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
Smart R
N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
[TBL] [Abstract][Full Text] [Related]
4. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
Ornstein DK; Rao GS; Smith DS; Andriole GL
J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
[TBL] [Abstract][Full Text] [Related]
5. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies.
Rovner ES; Schanne FJ; Malkowicz SB; Wein AJ
J Urol; 1997 Jul; 158(1):138-41; discussion 141-2. PubMed ID: 9186340
[TBL] [Abstract][Full Text] [Related]
6. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Associated Factors of Incidentally Diagnosed Prostatic Carcinoma among Patients Who Had Transurethral Prostatectomy in Tanzania: A Retrospective Study.
Gunda D; Kido I; Kilonzo S; Nkandala I; Igenge J; Mpondo B
Ethiop J Health Sci; 2018 Jan; 28(1):11-18. PubMed ID: 29622903
[TBL] [Abstract][Full Text] [Related]
9. Urinary prostate specific antigen: is the clinical use likely?
Pejcic T; Hadzi-Djokic J; Acimovic M; Topuzovic C; Milkovic B; Janjic A
Acta Chir Iugosl; 2005; 52(4):69-74. PubMed ID: 16673599
[TBL] [Abstract][Full Text] [Related]
10. Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making.
Nnabugwu II; Ugwumba FO; Enivwenae OA; Udeh EI; Otene CO; Nnabugwu CA
Clin Interv Aging; 2015; 10():89-93. PubMed ID: 25565791
[TBL] [Abstract][Full Text] [Related]
11. Are transrectal prostate biopsies routinely indicated in patients with incidentally diagnosed prostate cancer following transurethral resection of the prostate for benign disease?
Lee LS; Thiruneelakandasivam S; Hong MK; Peters JS; Warren A; Mills R; Greenberg D; Wright K; Gnanapragasam V
Urol Int; 2013; 91(4):397-403. PubMed ID: 23921216
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer detection in candidates for open prostatectomy.
Fowler JE; Bigler SA; Kolski JM
J Urol; 1998 Dec; 160(6 Pt 1):2107-10. PubMed ID: 9817333
[TBL] [Abstract][Full Text] [Related]
13. Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study.
Yang XJ; Lecksell K; Short K; Gottesman J; Peterson L; Bannow J; Schellhammer PF; Fitch WP; Hodge GB; Parra R; Rouse S; Waldstreicher J; Epstein JI
Urology; 1999 Apr; 53(4):696-700. PubMed ID: 10197843
[TBL] [Abstract][Full Text] [Related]
14. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of cyclooxygenase-2 over expression for identifying prostate cancer from benign prostatic hyperplasia in prostate biopsy specimens.
Ceylan Y; Lekili M; Muezzinoglu T; Nese N; Isisag A
Minerva Urol Nefrol; 2016 Jun; 68(3):255-62. PubMed ID: 26125280
[TBL] [Abstract][Full Text] [Related]
16. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
17. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement.
Bhuiyan AK; Kibria SA; Subhan SS
Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):51-9. PubMed ID: 15813483
[TBL] [Abstract][Full Text] [Related]
18. [Systematic prostate biopsy before transurethral resection of the prostate].
Hayakawa T; Kanemitsu N; Mitsuya H; Hayase Y; Kojima M
Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):588-95. PubMed ID: 15103921
[TBL] [Abstract][Full Text] [Related]
19. [Omission factors in detecting early stage prostate cancer by TRUS needle biopsy].
Zhang SW; Guo HQ; Gan WD; Gong ZH; Sun ZY
Zhonghua Nan Ke Xue; 2005 Jun; 11(6):431-2, 437. PubMed ID: 15999487
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis.
van Iersel MP; Witjes WP; de la Rosette JJ; Oosterhof GO
Br J Urol; 1995 Jul; 76(1):47-53. PubMed ID: 7544204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]